Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 45
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Longden, Eleanor and Read, John 2016. Assessing and Reporting the Adverse Effects of Antipsychotic Medication. Clinical Neuropharmacology, Vol. 39, Issue. 1, p. 29.

    de Boer, M. K. Castelein, S. Wiersma, D. Schoevers, R. A. and Knegtering, H. 2015. The Facts About Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings. Schizophrenia Bulletin, Vol. 41, Issue. 3, p. 674.

    Lee, Ju-Yeon Kim, Sung-Wan Lee, Yo-Han Kang, Hee-Ju Kim, Seon-Young Bae, Kyung-Yeol Kim, Jae-Min Shin, Il-Seon and Yoon, Jin-Sang 2015. Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy. Human Psychopharmacology: Clinical and Experimental, Vol. 30, Issue. 6, p. 416.

    Smith, James Paul and Herber, Oliver Rudolf 2015. Ethical issues experienced by mental health nurses in the administration of antipsychotic depot and long-acting intramuscular injections: A qualitative study. International Journal of Mental Health Nursing, Vol. 24, Issue. 3, p. 222.

    de Boer, Marrit K. Castelein, Stynke Wiersma, Durk Schoevers, Robert A. and Knegtering, Henderikus 2014. A Systematic Review of Instruments to Measure Sexual Functioning in Patients Using Antipsychotics. The Journal of Sex Research, Vol. 51, Issue. 4, p. 383.

    de Boer, Marrit K. Oolders, Johannes M. van den Heuvel, Edwin R. Wiersma, Durk Schoevers, Robert A. and Knegtering, Henderikus 2014. Efficacy of Tadalafil on Erectile Dysfunction in Male Patients Using Antipsychotics. Journal of Clinical Psychopharmacology, Vol. 34, Issue. 3, p. 380.

    Kheng Yee, Ong Muhd Ramli, Eni Rahaiza and Che Ismail, Hasanah 2014. Remitted Male Schizophrenia Patients with Sexual Dysfunction. The Journal of Sexual Medicine, Vol. 11, Issue. 4, p. 956.

    Rubio-Abadal, Elena and Usall, Judith 2013. Hiperprolactinemia y tratamiento antipsicótico. Manifestaciones clínicas y manejo. Psiquiatría Biológica, Vol. 20, Issue. 3, p. 27.

    Tiwari, Prashant Chandy, Anish Kumar, Kuldip Mishra, Rahul and Ahirwar, Dheeraj 2013. Neuroleptic drug induced hyperprolactinaemia: Pathophysiology, safety and acceptability. Asian Pacific Journal of Reproduction, Vol. 2, Issue. 1, p. 69.

    Nosè, Michela Mazzi, Maria Angela Esposito, Eleonora Bianchini, Marco Petrosemolo, Paola Ostuzzi, Giovanni Tansella, Michele and Barbui, Corrado 2012. Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspective. Social Psychiatry and Psychiatric Epidemiology, Vol. 47, Issue. 1, p. 157.

    Park, Yeon Won Kim, Yooseok and Lee, Jun Ho 2012. Antipsychotic-Induced Sexual Dysfunction and Its Management. The World Journal of Men's Health, Vol. 30, Issue. 3, p. 153.

    Mahmoud, Ahmed Hayhurst, Karen P. Drake, Richard J. and Lewis, Shôn W. 2011. Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial. Schizophrenia Research and Treatment, Vol. 2011, p. 1.

    Zhang, Xiang Rong Zhang, Zhi Jun Jenkins, Trisha A. Cheng, Wei Rong and Reynolds, Gavin P. 2011. The Dose‐Dependent Effect of Chronic Administration of Haloperidol, Risperidone, and Quetiapine on Sexual Behavior in the Male Rat. The Journal of Sexual Medicine, Vol. 8, Issue. 12, p. 3345.

    Brotto, Lori A and Klein, Carolin 2010. Psychological factors involved in women’s sexual dysfunctions. Expert Review of Obstetrics & Gynecology, Vol. 5, Issue. 1, p. 93.

    Moritz, Steffen Veckenstedt, Ruth Randjbar, Sarah Vitzthum, Francesca Karow, Anne and Lincoln, Tania M. 2010. Course and determinants of self‐esteem in people diagnosed with schizophrenia during psychiatric treatment. Psychosis, Vol. 2, Issue. 2, p. 144.

    Pope, A. Adams, C. Paton, C. Weaver, T. and Barnes, T. R. E. 2010. Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used. The British Journal of Psychiatry, Vol. 197, Issue. 1, p. 67.

    Baggaley, Martin 2008. Sexual dysfunction in schizophrenia: focus on recent evidence. Human Psychopharmacology: Clinical and Experimental, Vol. 23, Issue. 3, p. 201.

    Byerly, Matthew Suppes, Trisha Tran, Quynh-Van and Baker, Ross A. 2007. Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders. Journal of Clinical Psychopharmacology, Vol. 27, Issue. 6, p. 639.

    Covell, Nancy H. Weissman, Ellen M. Schell, Bonnie McCorkle, Brian H. Summerfelt, W. Thomas Weiden, Peter J. and Essock, Susan M. 2007. Distress with Medication Side Effects among Persons with Severe Mental Illness. Administration and Policy in Mental Health and Mental Health Services Research, Vol. 34, Issue. 5, p. 435.

    Fan, Xiaoduo Henderson, David C. Chiang, Elaine Briggs, Leah B. Namey Freudenreich, Oliver Evins, A. Eden Cather, Corinne and Goff, Donald C. 2007. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophrenia Research, Vol. 94, Issue. 1-3, p. 119.


Subjective utility ratings of neuroleptics in treating schizophrenia*

  • Stephen E. Finn (a1), J. Michael Bailey (a1), Robert T. Schultz (a1) and Raymond Faber (a1)
  • DOI:
  • Published online: 01 July 2009

This study developed a method for measuring subjective costs and benefits of psychiatric treatments. Forty-one patients rated the relative bothersomeness of symptoms of schizophrenia and side effects of neuroleptics. Thirty-four psychiatrists made parallel ratings from the perspective of the average patient (individual utility) and of the patient's family and society (institutional utility). Psychiatrists predicted patients' ratings moderately well, but misjudged the bothersomeness to patients of 24% of side effects and 20% of symptoms. When considering the patient's perspective, both schizophrenic patients and psychiatrists rated symptoms as no more bothersome than side effects. However, psychiatrists saw side effects as significantly less bothersome than symptoms when considering costs to society. The subjective utility of neuroleptic medications for schizophrenia is most justifiable from an institutional perspective.

Corresponding author
1Address for correspondence: Dr Stephen E. Finn, Mezes Hall 330, University of Texas, Austin, TX 78712, USA.
Hide All

Parts of this paper were presented at the meeting of the Society of Biological Psychiatry, 7 13 May 1988, Montreal, Canada.

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

T. R. Crow (1985). The two syndrome concept: origins and current status. Schizophrenia Bulletin 11, 471485.

S. E. Finn (1982). Base rates, utilities, and DSM-III: shortcomings of fixed-rules systems of psychodiagnosis. Journal of Abnormal Psychology 91, 294302.

S. C. Hayes , R. O. Nelson & R. B. Jarrett (1987). The treatment utility of assessment: a functional approach to evaluating assessment quality. American Psychologist 42, 963974.

P. E. Meehl & A. Rosen (1955). Antecedent probability and the efficiency of psychometric signs, patterns, or cutting scores. Psychological Bulletin 52, 194216.

L. G. Rorer , P. J. Hoffman & K. C. Hsieh (1966). Utilities as base-rate multipliers in the determining of optimum cutting scores for the discrimination of groups of unequal size and variance. Journal of Applied Psychology 50, 364368.

R. L. Spitzer , N. C. Andreasen & J. Endicott (1978). Schizophrenia and other psychotic disorders in DSM-III. Schizophrenia Bulletin 4, 489494.

T. S. Szasz (1957). Some observations on the use of the tranquilizing drugs. Archives of Neurological Psychiatry 77, 8692.

T. Van Putten (1974). Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31, 6772.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *